Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 3, March 2026

    March 11, 2026

    Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

    March 11, 2026

    Longevity Swap Activity Expected to Rise as Run-Ons Look More Attractive

    March 11, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

      February 11, 2026

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

      January 21, 2026

      Longevity Swap Activity Expected to Rise as Run-Ons Look More Attractive

      March 11, 2026

      Athora’s Deal to Purchase Pension Insurance Corporation Receives Regulatory Approval

      March 9, 2026

      Safeway Pension Scheme Completes Bulk Purchase Annuity Buy-In With Canada Life

      March 5, 2026
      Milliman

      US Competitive Pension Risk Transfer Cost Increased in January

      March 2, 2026

      Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI

      February 11, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

      March 11, 2026

      Regulatory Changes Abound in Offshore US Life/Annuity Sidecar Market but Macro Picture Is the Most Likely Determinant of Further Growth

      March 11, 2026

      Kosmos Management Announces Seventh Asset-Backed Securitisation

      March 5, 2026

      More UK Life Insurer Equity Release Securitisation on the Horizon?

      February 25, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

      March 11, 2026

      Longevity Swap Activity Expected to Rise as Run-Ons Look More Attractive

      March 11, 2026

      Regulatory Changes Abound in Offshore US Life/Annuity Sidecar Market but Macro Picture Is the Most Likely Determinant of Further Growth

      March 11, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    UK Smoking Bill Likely to Deliver Only Modest Improvements to Future Life Expectancy

    Mortality November 13, 2024By Aaron Woolner
    Share
    Twitter LinkedIn Email

    Smoking rates in the UK have been falling since records were first taken in 1974, having previously reached levels of over 80% of men in the late 1940s, according to anti-smoking lobby group, Ash, which now estimates around 13% of the country’s population uses nicotine.

    The UK’s new Labour government is aiming to drive these numbers down even further and on 5th November it introduced the Tobacco and Vapes Bill which, if put onto the statute book, will mean that children aged 15 in 2024 will never legally be able to purchase tobacco products.

    The UK isn’t the first country to attempt to raise a ‘smoke free’ generation. New Zealand’s parliament passed pioneering legislation in 2022 which would have stopped anyone born after 2009 from buying cigarettes. However, this was repealed after the election of a coalition government in 2023.

    The chances of the UK successfully – partially – banning smoking appears much higher. The Labour government won the biggest majority in the country’s modern history with its July election victory and the smoking ban itself was first proposed by the previous Conservative government.

    The UK’s smoking death numbers are currently trending downwards with the country’s state health service reporting 74,600 deaths attributable to smoking in 2019, a 3% fall compared with 2018 and a 9% decline relative to 2009.

    However, Nicky Draper, Longevity Consultant at Crystallise, says that given the long timelines involved with nicotine-linked diseases, it will be some time before the proposed legislation has a material impact on smoking deaths.

    “The incremental smoking ban, which increases the age it’s possible to buy tobacco by a year every 12 months, is public health policy at its best because the people who enact these measures are unlikely to witness the full extent of the changes it brings,” she said.

    “This is chiefly because of the long time-lag between smoking behaviour and ill-health effects. Even for lung cancer, it’s probably 20 years before symptoms come along, and it’s the same for cardiovascular diseases.”

    The current timelines for the partial smoking ban envisage current 15-year-olds being barred from buying nicotine in 2027. This means that even with the UK’s current state retirement age of 66, it will be 2079 before the first cohort to be affected by the ban reaches pensioner status.

    “Because of the Tobacco and Vapes Bill’s incremental nature, what we will see is a modest impact on mortality in 20 to 30 years from now. But that effect will start to grow, and the aim is to ultimately produce a smoke free generation over the long term,” Draper said.

    The gradual approach towards phasing out nicotine contrasts markedly with the prohibition approach which has typically been applied to reducing drug consumption, so why not go straight ahead with an outright ban?

    Draper says the problem lies with the sheer addictiveness of nicotine; the US Surgeon General warned in 1988 that nicotine was as addictive as the universally proscribed drugs cocaine and heroin.

    Because of the strong withdrawal effects from nicotine, numerous studies have shown that smoking cessation attempts, which are supported by nicotine replacement therapy, have much better success rates than simply stopping cold.

    “Quitting smoking is difficult, but by and large, evidence tells us that those who have the support of a structured smoking cessation program, such the one which is offered through the NHS, are the most successful,” Draper says.

    Draper adds that it is simply not possible to provide sufficient support to the UK’s estimated six million smokers if nicotine was simply banned at a stroke.

    The problems with providing support to all UK smokers in a wholesale nicotine ban scenario is exacerbated by the wide disparity in smoking rates between different socioeconomic groups. While the UK’s headline smoking rate of just under 13% is much lower than similar sized neighbouring countries Germany (21.5%), and France (34.6%), this masks a broad differential between social groups.

    The UK’s Office of National Statistics’ Index of Multiple Deprivation classifies populations into ten subgroups. According to the 2021 UK Census data, roughly one-third (33.1%) of English smokers lived in the two most deprived deciles. In contrast, the least deprived neighbourhoods recorded smoking rates of just 6.8%.

    “So how do you support everybody if you suddenly ban smoking? And is there a potential for a ban of this type to turn into an underground situation where people are then accessing black market cigarettes because the support to quit isn’t there?” said Draper.

    The UK government also announced that disposable vapes will be banned from 1st June 2025 under separate environmental legislation. The ban follows concerns over a marked increase in vaping among young adults who had not previously smoked.

    The move to ban disposable vapes means that more than half of countries now have some form of e-cigarette restrictions in place – 33 have banned vapes sale outright, while another 87 have some form of restriction in place.

    While the move to outlaw disposable vapes has its genesis in environmental concerns, there is evidence to suggest that vaping is a gateway to nicotine addiction, that bypasses cigarette use, so a crackdown could have an impact here as well. But this two-pronged approach to reducing smoking is, according to Draper, a long game here, and while there is unlikely to be an impact on mortality data in the short to medium-term, there could be additional benefits down the line.

    “As I say, there will be only a modest impact on mortality in the UK, and it won’t be for another 20 to 30 years until we see that impact,” said Draper.

    “But there will still be an impact, and it’s also important to remember the potential knock-on effects. Smoking costs the NHS billions of pounds a year, and significantly reducing the amount of resources that go into managing smoking-related illnesses can then be deployed elsewhere.”

    2024 - November Clinical Mortality Mortality Risk Volume 3 Issue 11 - November 2024
    Share. Twitter LinkedIn Email

    Related Posts

    US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

    February 25, 2026By Jamie Tucker and Jack Rosen

    Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

    February 11, 2026By Roger Lawrence

    10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

    January 28, 2026By Febby Mulewa and Maura Feddersen

    Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

    January 21, 2026By LMI Newsdesk
    Latest Issue

    Investor Consensus Emerging as Life Settlements Considered ‘Resilience’ Allocation, but Education Requirement Remains

    February 11, 2026

    US Plan Sponsors Are Turning to OCIOs for Buy-Out Readiness

    February 11, 2026

    Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI

    February 11, 2026

    Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

    February 11, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.